August 12, 2025 06:57 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Election Commission summons Bengal CS Manoj Pant to Delhi after Mamata govt snubbed order to suspend 4 officers | 'Abhi picture baaki hai': Rahul Gandhi relaunches attack on Election Commission over 'voter fraud' | Zelenskyy, Modi discuss bilateral ties, Russia conflict | Lok Sabha Speaker Om Birla forms probe panel against Justice Yashwant Varma over corruption allegations | 'These voiceless souls are not problems to be erased': Rahul Gandhi on Supreme Court order to remove stray dogs | 'Effective sterilisation programme is needed': PETA India calls Supreme Court's stray dogs removal order 'unscientific' | Osama Bin Laden in a suit: Former Pentagon official Rubin slams Asim Munir over recent nuclear rhetoric | Pakistan Army chief Asim Munir now threatens to target Mukesh Ambani's Jamnagar refinery | Nuclear sabre-rattling is Pakistan’s stock-in-trade: India on Asim Munir's remark | Supreme Court orders relocation of Delhi-NCR stray dogs to shelters amid rise in rabies death cases
Sputnik V

One dose of Russia's Sputnik V vaccine to cost less than $10 for int'l markets - RDIF

| @indiablooms | Nov 24, 2020, at 10:11 pm

Moscow/Sputnik: One dose of Russia's Sputnik V vaccine against COVID-19 will cost less than $10 for the international markets, which is two or more times cheaper than alternatives by Pfizer and Moderna, the Russian Direct Investment Fund (RDIF) announced on Tuesday.

While vaccines by US biotechnology company Moderna and the Pfizer pharmaceutical corporation are mRNA-based, like many other vaccine candidates, Russia's Sputnik V is based on the well-research method of human adenoviral vectors.

"The cost of the Russian Sputnik V vaccine for international markets will be less than $10 per dose starting from February 2021, which is less than $20 for the two doses necessary to vaccinate one person. Thus, Sputnik V will be two or more times cheaper than foreign vaccines based on mRNA technology with similar efficacy rates," RDIF said in a press release. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu